Accelerate Diagnostics (AXDX)

• Market cap: $29.1M
• 1 day: -2.52%
• 5 days: -14.07%
• 1 month: -31.76%
• 3 months: -24.68%
• 6 months: -7.20%
• Year to date: -72.58%
• 1 year: -73.39%
• 5 years: -99.32%
• 10 years: -99.40%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Employees: 134

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

3,300% more call options, than puts

Call options by funds: $34K | Put options by funds: $1K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

66% more capital invested

Capital invested by funds: $5.02M [Q2] → $8.33M (+$3.31M) [Q3]

12% more funds holding

Funds holding: 41 [Q2] → 46 (+5) [Q3]

0.83% more ownership

Funds ownership: 19.48% [Q2] → 20.3% (+0.83%) [Q3]

69% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 13